Drug Type Small molecule drug |
Synonyms CHE-202, NOV-202 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H24N6O |
InChIKeyFXOYHUWXURVZRT-UHFFFAOYSA-N |
CAS Registry1401070-57-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Cancer | Preclinical | SE | 29 Aug 2022 | |
Refractory Cancer | Preclinical | SE | 29 Aug 2022 |